Your browser doesn't support javascript.
loading
Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals.
Klatt, Nichole R; Bosinger, Steven E; Peck, Melicent; Richert-Spuhler, Laura E; Heigele, Anke; Gile, Jillian P; Patel, Nirav; Taaffe, Jessica; Julg, Boris; Camerini, David; Torti, Carlo; Martin, Jeffrey N; Deeks, Steven G; Sinclair, Elizabeth; Hecht, Frederick M; Lederman, Michael M; Paiardini, Mirko; Kirchhoff, Frank; Brenchley, Jason M; Hunt, Peter W; Silvestri, Guido.
Afiliação
  • Klatt NR; Department of Pharmaceutics, Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United Sta
  • Bosinger SE; Yerkes Primate Research Center, Emory Vaccine Center and Department of Pathology, Emory University, Atlanta, Georgia, United States of America.
  • Peck M; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
  • Richert-Spuhler LE; Department of Pharmaceutics, Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America.
  • Heigele A; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
  • Gile JP; Department of Pharmaceutics, Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America.
  • Patel N; Yerkes Primate Research Center, Emory Vaccine Center and Department of Pathology, Emory University, Atlanta, Georgia, United States of America.
  • Taaffe J; Yerkes Primate Research Center, Emory Vaccine Center and Department of Pathology, Emory University, Atlanta, Georgia, United States of America.
  • Julg B; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America.
  • Camerini D; Institute for Immunology, University of California Irvine, Irvine, California, United States of America.
  • Torti C; Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy.
  • Martin JN; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
  • Deeks SG; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
  • Sinclair E; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
  • Hecht FM; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
  • Lederman MM; Division of Infectious Diseases, Case Western Reserve University/University Hospitals Case Medical Center, Cleveland, Ohio, United States of America.
  • Paiardini M; Yerkes Primate Research Center, Emory Vaccine Center and Department of Pathology, Emory University, Atlanta, Georgia, United States of America.
  • Kirchhoff F; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
  • Brenchley JM; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Hunt PW; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
  • Silvestri G; Yerkes Primate Research Center, Emory Vaccine Center and Department of Pathology, Emory University, Atlanta, Georgia, United States of America.
PLoS Pathog ; 10(8): e1004345, 2014 Aug.
Article em En | MEDLINE | ID: mdl-25167059
ABSTRACT
A rare subset of HIV-infected individuals, designated viremic non-progressors (VNP), remain asymptomatic and maintain normal levels of CD4+ T-cells despite persistently high viremia. To identify mechanisms potentially responsible for the VNP phenotype, we compared VNPs (average >9 years of HIV infection) to HIV-infected individuals who have similar CD4+ T-cell counts and viral load, but who are likely to progress if left untreated ("putative progressors", PP), thus avoiding the confounding effect of differences related to substantial CD4+ T cell depletion. We found that VNPs, compared to PPs, had preserved levels of CD4+ stem cell memory cells (TSCM (p<0.0001), which was associated with decreased HIV infection of these cells in VNPs (r = -0.649, p = 0.019). In addition, VNPs had decreased HIV infection in CD4+ central memory (TCM) cells (p = 0.035), and the total number of TCM cells was associated with increased proliferation of memory CD4+ T cells (r = 0.733, p = 0.01). Our results suggest that, in HIV-infected VNPs, decreased infection of CD4+ TCM and TSCM, cells are involved in preservation of CD4+ T cell homeostasis and lack of disease progression despite high viremia.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Viremia / Linfócitos T CD4-Positivos / Infecções por HIV / Subpopulações de Linfócitos T / Memória Imunológica Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Viremia / Linfócitos T CD4-Positivos / Infecções por HIV / Subpopulações de Linfócitos T / Memória Imunológica Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article